IperionX Limited carries a market capitalization of 1.34B, placing it among publicly traded companies globally.
| Market Cap | 1.34B |
| Enterprise Value | N/A |
IperionX Limited maintains a current ratio of 25.42, meaning it holds 25.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 25.42 |
| Quick Ratio | 23.32 |
| Debt / Equity | 6.87 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
IperionX Limited's stock has gained approximately 63.30876% over the past 52 weeks. The 50-day moving average sits at 33.22, while the 200-day moving average is 40.67.
| Beta (5Y) | N/A |
| 52-Week Price Change | 63.30876% |
| 50-Day Moving Average | 33.22 |
| 200-Day Moving Average | 40.67 |
| Average Volume (20 Days) | N/A |
| Operating Cash Flow | N/A |
| Capital Expenditures | -14.05M |
| Free Cash Flow | -14.05M |
| FCF Per Share | N/A |
IperionX Limited posts an Altman Z-Score of -1.42, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.42 |